Project Grant HT94252410608
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$825K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94301, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $358,245 Project Grant to the Massachusetts Eye And Ear Infirmary on May 15, 2024 for the project "IN SILICO SCREEN AND IN VIVO EVALUATION OF FDA-APPROVED DRUGS TO TREAT NOISE-INDUCED HEARING LOSS". The grant supports a two-year effort to screen FDA-approved drugs and evaluate the most promising compounds for their ability to protect against noise-induced hearing loss in cell...
This $1.42M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Miami to prevent hidden hearing loss and synaptopathy following noise overexposure through targeted temperature management. The 3-year grant, awarded on July 15, 2023, will fund this study focused on improving medical solutions for the battlefield and transforming health care for Service Members and the public through...
The University of Cincinnati, through its Sponsored Research Services Division, was awarded a $357,989 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, entitled "MAGNETOPHOTOTHERMAL NANOPARTICLE DRUG DELIVERY FOR TREATING NOISE-INDUCED HEARING LOSS", will fund advanced biomedical research to develop innovative therapeutic approaches for addressing noise-induced hearing loss in military service...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $371,627 to the University of Texas Medical Branch at Galveston (UTMB) to support research on "TARGETING RETINOID ACID METABOLIC PATHWAY TO TREAT NOISE-INDUCED HEARING LOSS". The research aims to investigate the use of selective CYP26 inhibitors as a treatment for noise-induced hearing loss, with potential to transform care for Service Members and...
The Department of the Army Medical Command awarded Case Western Reserve University a $402,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support the repurposing of a therapeutic candidate to mitigate synaptopathy and associated hearing loss. The two-year award, beginning September 1, 2021, will fund research activities at Case Western Reserve University and its affiliated University Hospitals of Cleveland location in Cleveland, Ohio to...
The University of Miami received a $1,534,759 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "RESTORATION OF INNER EAR CELLS IN THE HEARING LOSS-ASSOCIATED HUMAN INNER EAR SYSTEM". This 3-year award, with a period of performance from September 30, 2023 to September 29, 2026, will support the university's biomedical research efforts focused on developing new treatments and...
The Defense Health Agency has awarded a $1,370,529 Cooperative Agreement under the Military Medical Research and Development program (CFDA 12.420) to the Massachusetts Eye and Ear Infirmary. The funding supports a 3-year project to investigate the regeneration of synapses to treat synaptopathy (damage to synaptic connections) following noise exposure, with the goal of transforming healthcare for Service Members and the American public. As a sub-award under this grant, The Geneva Foundation...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $824,505 Project Grant to the Sunnybrook Research Institute in Canada. The funding will support novel therapeutic and delivery strategies for primary auditory neuron regeneration research over a 3-year period from August 1, 2024 to July 31, 2027. The Sunnybrook Research Institute, a leading Canadian biomedical research center, will leverage its expertise in neuroscience,...
This three-year Project Grant from the Defense Health Agency, totaling $847,194, will support research on "BIOMARKERS OF HYPERACUSIS IN AUTISM SPECTRUM DISORDER" at the University of Texas at Dallas from September 2023 through September 2026. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health...
The Department of the Army Medical Command awarded a $402,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Case Western Reserve University (CWRU) to conduct research on repurposing an FDA-approved drug to mitigate noise-induced hearing loss. The project will be performed in Cleveland, Ohio from May 1, 2025 to April 30, 2027. As a leading research university with expertise in biomedical, engineering, and scientific domains, CWRU will leverage its...